ArticleFrontiers in immunology2023

Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma.

Deepak Rohila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.